Life Sciences

GVSU Students Develop Hand Sanitizing Product For Health Care Workers

GRAND RAPIDS - A group of Grand Valley State University students has developed a series of devices for a Michigan-based company that addresses a common problem for health care workers: keeping hands sanitized and clean.  Grand Valley's applied Medical Device Institute worked with Sterilogy to develop the hand hygiene compliance system with a goal to reduce hospital

By |2018-11-09T10:55:48-05:00November 9th, 2018|Life Sciences|

Esperion Sees Positive Results From Final Study On Cholesterol-Buster

ANN ARBOR — Esperion Therapeutics Inc., the Ann Arbor-based pharmaceutical developer, announced positive results from the final Phase 3 test of its lead drug candidate, bempedoic acid. The company said a global, pivotal Phase 3 clinical study (Study 1002-047) showed that a dose of 180 milligrams per day of the drug showed additional lowering of

By |2018-10-31T19:37:08-04:00October 31st, 2018|ESD, Life Sciences|

West Michigan Medical Device Company Closes On $2.5 Million Series A Round

HOLLAND — Shoulder Innovations Inc. closed on $2.5 million in a Series A equity funding round led by the Michigan Angel Fund of Ann Arbor. The additional capital will go to support new product development and to acquire inventory and assets needed to accelerate growth of the Inset platform for future products and systems now in development. “It is

By |2018-10-25T09:47:03-04:00October 25th, 2018|Entrepreneurs, Life Sciences, Life Sciences/Biotech|

Genomenon Partners With Rare Genomics Institute

ANN ARBOR -  Genomenon announced today that they will donate Mastermind Genomic Search Engine licenses to the entire team of clinical scientists at Rare Genomics Institute to accelerate their work for patients with rare diseases.  Rare Genomics Institute (RG) is a nonprofit organization that has been at the forefront of providing direct support to undiagnosed rare disease patients and

By |2018-10-21T18:05:52-04:00October 21st, 2018|Life Sciences|

New DNA Tool Predicts Height, Shows Promise for Serious Illness Assessment

EAST LANSING - A new DNA tool created by Michigan State University can accurately predict people’s height, and more importantly, could potentially assess their risk for serious illnesses, such as heart disease and cancer. Stephen Hsu, Vice President for Research and Graduate Studies. For the first time, the tool, or algorithm, builds predictors for human

By |2018-10-21T18:00:52-04:00October 21st, 2018|Life Sciences, New Products / Contracts|

Henry Ford Health System, Wayne State To Expand Partnership In Patient Care

DETROIT –Henry Ford Health System and Wayne State University announced Friday the organizations have signed a letter of intent to expand their long-term partnership and bring the two Detroit anchor institutions even closer together. This new partnership will create a collaborative model focused on achieving the highest levels of excellence in patient care, a transformational

By |2018-09-28T12:44:41-04:00September 28th, 2018|Life Sciences, Life Sciences/Biotech, News|

MSU Researchers Create Synthetic Biological Devices To Treat Chronic, Uncured Diseases

EAST LANSING - Michigan State University engineering researchers are working to create ‘synthetic biological-devices’ inside the cells of mammals that will enable new treatments for chronic and uncured diseases. A cross-disciplinary team of biomedical and electrical engineers will build biological circuits, oscillators, and toggle switches inside cells to respond to electromagnetic fields as a mean

By |2018-08-14T20:08:37-04:00August 14th, 2018|Life Sciences|

Fifth Eye Gets $2.36 Million Investment Lead by Invest Michigan, Biosciences Research and Commercialization Center

ANN ARBOR - Fifth Eye Inc., a digital health predictive analytics company, has received a $2.36 million investment from Invest Michigan, Biosciences Research and Commercialization Center, and 33 private angel investors. Fifth Eye develops real-time predictive analytic patient data software to give doctors and nurses a heads up hours in advance about impending trouble ranging

By |2018-07-31T15:39:16-04:00July 31st, 2018|Entrepreneurs, Life Sciences|

Genomenon Wins Phase 2 Small Business Innovation Research Grant

ANN ARBOR - Genomic Data Search company Genomenon has been awarded a Phase 2 Small Business Innovation Research grant by the National Institutes of Health. The amount was not disclosed. The grant will be used to develop and apply machine learning and artificial intelligence algorithms to variant interpretation, the single biggest hurdle in scaling the

By |2018-07-31T09:33:14-04:00July 31st, 2018|Life Sciences|